Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo

Autores:
Reyna Villasmil, Eduardo
Mejia-Montilla, Jorly
Reyna-Villasmil, Nadia
Torres-Cepeda, Duly
Fernández-Ramírez , Andreina
Tipo de recurso:
Article of journal
Fecha de publicación:
2021
Institución:
Fundación Universitaria de Ciencias de la Salud - FUCS
Repositorio:
Repositorio Digital Institucional ReDi
Idioma:
spa
OAI Identifier:
oai:repositorio.fucsalud.edu.co:001/2976
Acceso en línea:
https://repositorio.fucsalud.edu.co/handle/001/2976
https://doi.org/10.31260/RepertMedCir.01217372.1040
Palabra clave:
cáncer de cuello uterino
radioterapia
5-fluorouracilo
cisplatino
cervical cancer
radiotherapy
5-fluorouracil
cisplatin
Rights
openAccess
License
Revista Repertorio de Medicina y Cirugía - 2021
id FUCS2_5f907bdc4b078d628021c2834d0053c3
oai_identifier_str oai:repositorio.fucsalud.edu.co:001/2976
network_acronym_str FUCS2
network_name_str Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
dc.title.translated.eng.fl_str_mv Radiotherapy and 5-fluorouracil-cisplatin treatment for high-risk uterine cervical cancer
title Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
spellingShingle Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
cáncer de cuello uterino
radioterapia
5-fluorouracilo
cisplatino
cervical cancer
radiotherapy
5-fluorouracil
cisplatin
title_short Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
title_full Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
title_fullStr Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
title_full_unstemmed Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
title_sort Radioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgo
dc.creator.fl_str_mv Reyna Villasmil, Eduardo
Mejia-Montilla, Jorly
Reyna-Villasmil, Nadia
Torres-Cepeda, Duly
Fernández-Ramírez , Andreina
dc.contributor.author.spa.fl_str_mv Reyna Villasmil, Eduardo
Mejia-Montilla, Jorly
Reyna-Villasmil, Nadia
Torres-Cepeda, Duly
Fernández-Ramírez , Andreina
dc.subject.spa.fl_str_mv cáncer de cuello uterino
radioterapia
5-fluorouracilo
cisplatino
topic cáncer de cuello uterino
radioterapia
5-fluorouracilo
cisplatino
cervical cancer
radiotherapy
5-fluorouracil
cisplatin
dc.subject.eng.fl_str_mv cervical cancer
radiotherapy
5-fluorouracil
cisplatin
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2021-11-11 12:35:05
2022-06-29T19:38:29Z
dc.date.issued.none.fl_str_mv 2021-11-11
dc.date.available.none.fl_str_mv 2021-11-11 12:35:05
2022-06-29T19:38:29Z
dc.type.spa.fl_str_mv Artículo de revista
dc.type.eng.fl_str_mv Journal article
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv Text
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.31260/RepertMedCir.01217372.1040
dc.identifier.issn.none.fl_str_mv 0121-7372
dc.identifier.uri.none.fl_str_mv https://repositorio.fucsalud.edu.co/handle/001/2976
dc.identifier.eissn.none.fl_str_mv 2462-991X
dc.identifier.url.none.fl_str_mv https://doi.org/10.31260/RepertMedCir.01217372.1040
identifier_str_mv 10.31260/RepertMedCir.01217372.1040
0121-7372
2462-991X
url https://repositorio.fucsalud.edu.co/handle/001/2976
https://doi.org/10.31260/RepertMedCir.01217372.1040
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Galceran J, Ameijide A, Carulla M, Mateos A, Quirós JR, Rojas D, Alemán A, Torrella A, Chico M, Vicente M, Díaz JM, Larrañaga N, Marcos-Gragera R, Sánchez MJ, Perucha J, Franch P, Navarro C, Ardanaz E, Bigorra J, Rodrigo P, Bonet RP; REDECAN Working Group. Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017;19(7):799-825. doi: 10.1007/s12094-016-1607-9.
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524-548. doi: 10.1001/jamaoncol.2016.5688.
Kokka F, Bryant A, Brockbank E, Powell M, Oram D. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database Syst Rev. 2015;(4):CD010260. doi: 10.1002/14651858.CD010260.pub2.
Fregnani JH, de Oliveira Latorre Mdo R, Novik PR, Lopes A, de Oliveira JC, Tsunoda AT, Soares FA. Extent of pelvic lymphadenectomy in women with squamous cell carcinoma of the uterine cervix: is there any prognostic value? J Surg Oncol. 2009;100(3):252-7. doi: 10.1002/jso.21252.
Brambs CE, Höhn AK, Hentschel B, Fischer U, Bilek K, Horn LC. The prognostic impact of grading in FIGO IB and IIB squamous cell cervical carcinomas. Geburtshilfe Frauenheilkd. 2019;79(2):198-204. doi: 10.1055/a-0828-7681.
Trudel M, Merlot B, Dedet B, Faye N, Kerdraon O, Vinatier D, Collinet P. Is radical hysterectomy necessary in surgical procedure for early stage cervical cancer? Gynecol Obstet Fertil. 2013;41(12):715-21. doi: 10.1016/j.gyobfe.2013.10.002.
Sakakibara A, Matsui K, Katayama T, Higuchi T, Terakawa K, Konishi I. Age-related survival disparity in stage IB and IIB cervical cancer patients. J Obstet Gynaecol Res. 2019;45(3):686-694. doi: 10.1111/jog.13891.
Liu MT, Hsu JC, Liu WS, Wang AY, Huang WT, Chang TH, Pi CP, Huang CY, Huang CC, Chou PH, Chen TH. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy. Eur J Cancer Care (Engl). 2008;17(2):174-81. doi: 10.1111/j.1365-2354.2007.00831.x.
Chen L, Lü WG, Xie X, Chen HZ, Yu H, Ni XH. Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa. Zhonghua Fu Chan Ke Za Zhi. 2005;40(4):239-42.
Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, Zaino RJ. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2006;65(1):169-76.
Lee JW, Kim BG, Lee SJ, Lee SH, Park CS, Lee JH, Huh SJ, Bae DS. Preliminary results of consolidation chemotherapy following concurrent chemoradiation after radical surgery in high-risk early-stage carcinoma of the uterine cervix. Clin Oncol (R Coll Radiol). 2005;17(6):412-7. doi: 10.1016/j.clon.2005.02.006
Sartori E, Tisi G, Chiudinelli F, La Face B, Franzini R, Pecorelli S. Early stage cervical cancer: adjuvant treatment in negative lymph node cases. Gynecol Oncol. 2007;107(1 Suppl 1):S170-4. doi: 10.1016/j.ygyno.2007.07.026
Rushdan MN, Tay EH, Khoo-Tan HS, Lee KM, Low JH, Ho TH, Yam KL. Tailoring the field and indication of adjuvant pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma following radical surgery based on the GOG score--a pilot study. Ann Acad Med Singapore. 2004;33(4):467-72.
Mabuchi S, Morishige K, Isohashi F, Yoshioka Y, Takeda T, Yamamoto T, Yoshino K, Enomoto T, Inoue T, Kimura T. Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors. Gynecol Oncol. 2009;115(3):482-7. doi: 10.1016/j.ygyno.2009.09.002.
Reichert ZR, Wahl DR, Morgan MA. Translation of targeted radiation sensitizers into clinical trials. Semin Radiat Oncol. 2016;26(4):261-70. doi: 10.1016/j.semradonc.2016.06.001.
Petrelli F, De Stefani A, Raspagliesi F, Lorusso D, Barni S. Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysis. Gynecol Oncol. 2014;134(1):166-71. doi: 10.1016/j.ygyno.2014.04.049.
Stehman FB, Ali S, Keys HM, Muderspach LI, Chafe WE, Gallup DG, Walker JL, Gersell D. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol. 2007;197(5):503.e1-6. doi: 10.1016/j.ajog.2007.08.003
Cheewakriangkrai C, Srisomboon J, Chitapanarux I, Suprasert P, Phongnarisorn C, Siriaree S, Charoenkwan K. Concurrent cisplatin-based chemoradiation and adjuvant hysterectomy for bulky stage IB-IIA cervical cancer. J Med Assoc Thai. 2005;88(10):1331-7.
Valdes G, Iwamoto KS. Re-evaluation of cellular radiosensitization by 5-fluorouracil: high-dose, pulsed administration is effective and preferable to conventional low-dose, chronic administration. Int J Radiat Biol. 2013;89(10):851-62. doi: 10.3109/09553002.2013.797620.
Liu JL, Huang WS, Lee KC, Tung SY, Chen CN, Chang SF. Effect of 5-fluorouracil on excision repair cross-complementing 1 expression and consequent cytotoxicity regulation in human gastric cancer cells. J Cell Biochem. 2018;119(10):8472-8480. doi: 10.1002/jcb.27073.
Matsuo K, Shimada M, Aoki Y, Sakamoto M, Takeshima N, Fujiwara H, Matsumoto T, Mikami M, Sugiyama T. Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation. Int J Cancer. 2017;141(5):1042-1051. doi: 10.1002/ijc.30793.
Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22(5):872-80.
Datta NR, Stutz E, Liu M, Rogers S, Klingbiel D, Siebenhüner A, Singh S, Bodis S. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis. Gynecol Oncol. 2017;145(2):374-385. doi: 10.1016/j.ygyno.2017.01.033.
Tangjitgamol S, Katanyoo K, Laopaiboon M, Lumbiganon P, Manusirivithaya S, Supawattanabodee B. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. Cochrane Database Syst Rev. 2014;(12):CD010401. doi: 10.1002/14651858.CD010401.pub2.
Monk BJ, Wang J, Im S, Stock RJ, Peters WA 3rd, Liu PY, Barrett RJ 2nd, Berek JS, Souhami L, Grigsby PW, Gordon W Jr, Alberts DS; Gynecologic Oncology Group; Southwest Oncology Group; Radiation Therapy Oncology Group. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol. 2005;96(3):721-8. doi: 10.1016/j.ygyno.2004.11.007
dc.relation.bitstream.none.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/1786
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/1787
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/2036
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/1841
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/2037
dc.relation.citationedition.spa.fl_str_mv Núm. 3 , Año 2021
dc.relation.citationendpage.none.fl_str_mv 8
dc.relation.citationissue.spa.fl_str_mv 3
dc.relation.citationstartpage.none.fl_str_mv 1
dc.relation.citationvolume.spa.fl_str_mv 30
dc.relation.ispartofjournal.spa.fl_str_mv Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv Revista Repertorio de Medicina y Cirugía - 2021
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv Revista Repertorio de Medicina y Cirugía - 2021
https://creativecommons.org/licenses/by-nc-sa/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.mimetype.spa.fl_str_mv application/pdf
text/html
application/epub+zip
text/xml
audio/mpeg
dc.publisher.spa.fl_str_mv Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1040
institution Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv https://repositorio.fucsalud.edu.co/bitstreams/432703a9-a89e-4ecd-a5a7-8689c9d38143/download
bitstream.checksum.fl_str_mv 9eff08664a5aec1c22bf5bf737dc2652
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv redi@fucsalud.edu.co
_version_ 1811575303526416384
spelling Reyna Villasmil, Eduardo3b512367dfc5517e0abaabf4232b69c2500Mejia-Montilla, Jorlyf98346c606938951c1db4f0b15e73698500Reyna-Villasmil, Nadiadc8f8da3c50c29f7b60b58dee424e615500Torres-Cepeda, Duly29d2ed2c4220c25a2dea266fa9451e95500Fernández-Ramírez , Andreina0d7722869bd71bafc8a371bd6de6c8f65002021-11-11 12:35:052022-06-29T19:38:29Z2021-11-112021-11-11 12:35:052022-06-29T19:38:29ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludRevista Repertorio de Medicina y Cirugía - 2021info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1040cáncer de cuello uterinoradioterapia5-fluorouracilocisplatinocervical cancerradiotherapy5-fluorouracilcisplatinRadioterapia y 5-fluorouracilo-cisplatino en el tratamiento del cáncer de cuello uterino de alto riesgoRadiotherapy and 5-fluorouracil-cisplatin treatment for high-risk uterine cervical cancerapplication/pdftext/htmlapplication/epub+ziptext/xmlaudio/mpegArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.01217372.10400121-7372https://repositorio.fucsalud.edu.co/handle/001/29762462-991Xhttps://doi.org/10.31260/RepertMedCir.01217372.1040spaGalceran J, Ameijide A, Carulla M, Mateos A, Quirós JR, Rojas D, Alemán A, Torrella A, Chico M, Vicente M, Díaz JM, Larrañaga N, Marcos-Gragera R, Sánchez MJ, Perucha J, Franch P, Navarro C, Ardanaz E, Bigorra J, Rodrigo P, Bonet RP; REDECAN Working Group. Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017;19(7):799-825. doi: 10.1007/s12094-016-1607-9.Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524-548. doi: 10.1001/jamaoncol.2016.5688.Kokka F, Bryant A, Brockbank E, Powell M, Oram D. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database Syst Rev. 2015;(4):CD010260. doi: 10.1002/14651858.CD010260.pub2.Fregnani JH, de Oliveira Latorre Mdo R, Novik PR, Lopes A, de Oliveira JC, Tsunoda AT, Soares FA. Extent of pelvic lymphadenectomy in women with squamous cell carcinoma of the uterine cervix: is there any prognostic value? J Surg Oncol. 2009;100(3):252-7. doi: 10.1002/jso.21252.Brambs CE, Höhn AK, Hentschel B, Fischer U, Bilek K, Horn LC. The prognostic impact of grading in FIGO IB and IIB squamous cell cervical carcinomas. Geburtshilfe Frauenheilkd. 2019;79(2):198-204. doi: 10.1055/a-0828-7681.Trudel M, Merlot B, Dedet B, Faye N, Kerdraon O, Vinatier D, Collinet P. Is radical hysterectomy necessary in surgical procedure for early stage cervical cancer? Gynecol Obstet Fertil. 2013;41(12):715-21. doi: 10.1016/j.gyobfe.2013.10.002.Sakakibara A, Matsui K, Katayama T, Higuchi T, Terakawa K, Konishi I. Age-related survival disparity in stage IB and IIB cervical cancer patients. J Obstet Gynaecol Res. 2019;45(3):686-694. doi: 10.1111/jog.13891.Liu MT, Hsu JC, Liu WS, Wang AY, Huang WT, Chang TH, Pi CP, Huang CY, Huang CC, Chou PH, Chen TH. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy. Eur J Cancer Care (Engl). 2008;17(2):174-81. doi: 10.1111/j.1365-2354.2007.00831.x.Chen L, Lü WG, Xie X, Chen HZ, Yu H, Ni XH. Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa. Zhonghua Fu Chan Ke Za Zhi. 2005;40(4):239-42.Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, Zaino RJ. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2006;65(1):169-76.Lee JW, Kim BG, Lee SJ, Lee SH, Park CS, Lee JH, Huh SJ, Bae DS. Preliminary results of consolidation chemotherapy following concurrent chemoradiation after radical surgery in high-risk early-stage carcinoma of the uterine cervix. Clin Oncol (R Coll Radiol). 2005;17(6):412-7. doi: 10.1016/j.clon.2005.02.006Sartori E, Tisi G, Chiudinelli F, La Face B, Franzini R, Pecorelli S. Early stage cervical cancer: adjuvant treatment in negative lymph node cases. Gynecol Oncol. 2007;107(1 Suppl 1):S170-4. doi: 10.1016/j.ygyno.2007.07.026Rushdan MN, Tay EH, Khoo-Tan HS, Lee KM, Low JH, Ho TH, Yam KL. Tailoring the field and indication of adjuvant pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma following radical surgery based on the GOG score--a pilot study. Ann Acad Med Singapore. 2004;33(4):467-72.Mabuchi S, Morishige K, Isohashi F, Yoshioka Y, Takeda T, Yamamoto T, Yoshino K, Enomoto T, Inoue T, Kimura T. Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors. Gynecol Oncol. 2009;115(3):482-7. doi: 10.1016/j.ygyno.2009.09.002.Reichert ZR, Wahl DR, Morgan MA. Translation of targeted radiation sensitizers into clinical trials. Semin Radiat Oncol. 2016;26(4):261-70. doi: 10.1016/j.semradonc.2016.06.001.Petrelli F, De Stefani A, Raspagliesi F, Lorusso D, Barni S. Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysis. Gynecol Oncol. 2014;134(1):166-71. doi: 10.1016/j.ygyno.2014.04.049.Stehman FB, Ali S, Keys HM, Muderspach LI, Chafe WE, Gallup DG, Walker JL, Gersell D. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol. 2007;197(5):503.e1-6. doi: 10.1016/j.ajog.2007.08.003Cheewakriangkrai C, Srisomboon J, Chitapanarux I, Suprasert P, Phongnarisorn C, Siriaree S, Charoenkwan K. Concurrent cisplatin-based chemoradiation and adjuvant hysterectomy for bulky stage IB-IIA cervical cancer. J Med Assoc Thai. 2005;88(10):1331-7.Valdes G, Iwamoto KS. Re-evaluation of cellular radiosensitization by 5-fluorouracil: high-dose, pulsed administration is effective and preferable to conventional low-dose, chronic administration. Int J Radiat Biol. 2013;89(10):851-62. doi: 10.3109/09553002.2013.797620.Liu JL, Huang WS, Lee KC, Tung SY, Chen CN, Chang SF. Effect of 5-fluorouracil on excision repair cross-complementing 1 expression and consequent cytotoxicity regulation in human gastric cancer cells. J Cell Biochem. 2018;119(10):8472-8480. doi: 10.1002/jcb.27073.Matsuo K, Shimada M, Aoki Y, Sakamoto M, Takeshima N, Fujiwara H, Matsumoto T, Mikami M, Sugiyama T. Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation. Int J Cancer. 2017;141(5):1042-1051. doi: 10.1002/ijc.30793.Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22(5):872-80.Datta NR, Stutz E, Liu M, Rogers S, Klingbiel D, Siebenhüner A, Singh S, Bodis S. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis. Gynecol Oncol. 2017;145(2):374-385. doi: 10.1016/j.ygyno.2017.01.033.Tangjitgamol S, Katanyoo K, Laopaiboon M, Lumbiganon P, Manusirivithaya S, Supawattanabodee B. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. Cochrane Database Syst Rev. 2014;(12):CD010401. doi: 10.1002/14651858.CD010401.pub2.Monk BJ, Wang J, Im S, Stock RJ, Peters WA 3rd, Liu PY, Barrett RJ 2nd, Berek JS, Souhami L, Grigsby PW, Gordon W Jr, Alberts DS; Gynecologic Oncology Group; Southwest Oncology Group; Radiation Therapy Oncology Group. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol. 2005;96(3):721-8. doi: 10.1016/j.ygyno.2004.11.007https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/1786https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/1787https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/2036https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/1841https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1040/2037Núm. 3 , Año 202183130Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2933https://repositorio.fucsalud.edu.co/bitstreams/432703a9-a89e-4ecd-a5a7-8689c9d38143/download9eff08664a5aec1c22bf5bf737dc2652MD51001/2976oai:repositorio.fucsalud.edu.co:001/29762024-02-02 13:07:53.399https://creativecommons.org/licenses/by-nc-sa/4.0/Revista Repertorio de Medicina y Cirugía - 2021metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co